Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
07/02/2003 | EP1322592A1 Substituted 1-aminobutan-3-ol derivatives |
07/02/2003 | EP1322590A1 5-amino-1-pentene-3-ol substituted derivatives |
07/02/2003 | EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
07/02/2003 | EP1322350A1 E-ptfe foil impregnated with an encapsulated bioactive substance |
07/02/2003 | EP1322319A1 Use of il-8 protein modulators in the treatment of viral infections |
07/02/2003 | EP1322318A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
07/02/2003 | EP1322311A1 Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist |
07/02/2003 | EP1322310A1 Alpha v integrin receptor antagonists |
07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
07/02/2003 | EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
07/02/2003 | EP1322305A1 Use of r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature |
07/02/2003 | EP1322301A1 Combination particles for the treatment of asthma |
07/02/2003 | EP1322300A1 Inhalation particles incorporating a combination of two or more active ingredients |
07/02/2003 | EP1322299A2 Composition for the transdermal delivery of fentanyl |
07/02/2003 | EP1242092B1 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug |
07/02/2003 | EP1227825A4 Isolation and expansion of human marrow stromal cells |
07/02/2003 | EP1224180B1 Substituted azoles |
07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
07/02/2003 | EP1150666A4 Stimulating neutrophil function to treat inflammatory bowel disease |
07/02/2003 | EP1143994B1 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto)immune diseases |
07/02/2003 | EP1045849B1 Purine derivatives having phosphodiesterase iv inhibition activity |
07/02/2003 | EP1028954B1 Substituted imidazoles useful in the treatment of inflammatory diseases |
07/02/2003 | EP0970067B1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors |
07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
07/02/2003 | CN1427723A Composition for treatment of B-type hepatitis and liver cirrhosis |
07/02/2003 | CN1426809A Extenal use ointment for restoring period of knocks and falls |
07/02/2003 | CN1426801A Preparation method of pain relieving plaster |
07/02/2003 | CN1113059C Pipeazino derivatives as neurokinin antagonists |
07/02/2003 | CN1113057C Quinoline derivatives |
07/01/2003 | US6586603 Forming 4-(5-(4-chlorophenyl)-3-trifluoromethyl)-1H-pyrazol-1 -yl)benzenesulfonamide used as antiinflammatory agents; side effect reduction |
07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
07/01/2003 | US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
07/01/2003 | US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide |
07/01/2003 | US6586446 Chemotaxic cytokine agonists or antagonists such as N(3-acetylphlenyl)-N'-(-2-((-3-((4-fluorophenyl)methyl)-8 -azabicyclo(3.2.1)oct-8-yl)methyl)-(2R)-1-cyclohexyl)urea, used as antiinflammatory agents for asthma or allergies |
07/01/2003 | US6586432 Neurokinin-1 receptor antagonists |
07/01/2003 | US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
07/01/2003 | US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
07/01/2003 | US6586424 Anticancer agents; anticholesterol agents |
07/01/2003 | US6586423 Tyrosine kinase inhibitors |
07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
07/01/2003 | US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a |
07/01/2003 | US6586020 Bradykinin antagonists comprising rosaceae plant extracts |
07/01/2003 | US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes |
07/01/2003 | US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
06/26/2003 | WO2003052414A1 Screening method |
06/26/2003 | WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene |
06/26/2003 | WO2003052048A2 Nucleic acid-associated proteins |
06/26/2003 | WO2003051922A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
06/26/2003 | WO2003051921A1 Chemokine mutants acting as chemokine antagonists |
06/26/2003 | WO2003051893A2 Improvements in pharmaceutical compositions |
06/26/2003 | WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof |
06/26/2003 | WO2003051884A1 Fused indole compound, process for producing the same, and use |
06/26/2003 | WO2003051879A1 Known and novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones useful as poly(adp-ribose)polymerase inhibitors |
06/26/2003 | WO2003051878A1 Quinolinones as prostaglandin receptor ligands |
06/26/2003 | WO2003051870A1 Novel compounds |
06/26/2003 | WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
06/26/2003 | WO2003051868A1 Lactams as tachykinin antagonists |
06/26/2003 | WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS |
06/26/2003 | WO2003051859A1 Compounds for imaging alzheimer's disease |
06/26/2003 | WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
06/26/2003 | WO2003051844A1 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression |
06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
06/26/2003 | WO2003051833A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
06/26/2003 | WO2003051828A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
06/26/2003 | WO2003051825A1 Human adam-10 inhibitors |
06/26/2003 | WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds |
06/26/2003 | WO2003051807A2 Improvements in pharmaceutical compositions |
06/26/2003 | WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents |
06/26/2003 | WO2003051804A1 Novel substance having antitumor/anti-inflammatory activity |
06/26/2003 | WO2003051403A1 Treatment of osteomyelitis with radiopharmaceuticals |
06/26/2003 | WO2003051400A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
06/26/2003 | WO2003051393A2 Enzymatic cleavable reagents for specific delivery to disease sites |
06/26/2003 | WO2003051388A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
06/26/2003 | WO2003051385A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
06/26/2003 | WO2003051380A2 Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders |
06/26/2003 | WO2003051369A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
06/26/2003 | WO2003051363A1 Analgesic delivery systems and methods of use |
06/26/2003 | WO2003051361A1 Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation |
06/26/2003 | WO2003051353A1 Substituted beta-aminoalcohols used as medicaments |
06/26/2003 | WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
06/26/2003 | WO2003051315A2 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
06/26/2003 | WO2003051287A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
06/26/2003 | WO2003051277A2 Novel compounds |
06/26/2003 | WO2003032896A3 Dexibuprofen-containing soft gelatin capsules and process for preparing the same |
06/26/2003 | WO2003030920A9 An antispasmodic agent spaced drug delivery system |
06/26/2003 | WO2003020304A3 Inflammation modulatory compound comprising an endomorphin |
06/26/2003 | WO2003020005A3 Lp mammalian proteins; related reagents |
06/26/2003 | WO2002098352A3 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
06/26/2003 | WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
06/26/2003 | WO2002080945A3 Methods for treating the inflammatory component of a brain disorder |
06/26/2003 | WO2002046385A3 Enzymes |
06/26/2003 | US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction |
06/26/2003 | US20030120076 Vitreous form |
06/26/2003 | US20030119916 Treatment of functional gastrointestinal disorders |
06/26/2003 | US20030119903 Use of trimebutine for treating pain |
06/26/2003 | US20030119886 Nonsteroidal antiinflammatory agents, e.g., N-hydroxy-1-(4-sulfonyl or aminosulfonyl)phenyl)-(ring- substituted hetero-cyclyl)alkanamide or -urea; dual enzyme inhibitors with minimal side effects; asthma; antiallergens; antipyretics |
06/26/2003 | US20030119877 Pyridine derivatives useful as cyclooxygenase inhibitor |